Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Citigroup
BioCentury | Oct 24, 2024
Management Tracks
Junaid Bajwa joins Flagship as senior partner, head of U.K.
Plus: Promotions at Citigroup and updates from FDA’s CDRH, LigaChem, Alphina, Kenai and Precision Medicine
BioCentury | Sep 27, 2024
Finance
Wave financing, BioAge IPO help biotech end September strong
In BioCentury’s latest Public Equity Report, Wave raises $200M on standout DMD data and BioAge marks fourth NASDAQ IPO this month
BioCentury | Aug 24, 2024
Finance
Public Equity Report: Signs of life for biotech IPOs as Zenas, Bicara file, TYK sticks landing
Pair of well-funded late-stage biotechs seek NASDAQ listings, Shanghai cancer company prices deal in Hong Kong
BioCentury | Jun 28, 2024
Finance
Venture Report: Curie.Bio’s fund; megarounds for Formation, EvolutionaryScale, BillionToOne
Plus: New fundings for Exsilio, TwoStep and Augustine
BioCentury | Apr 30, 2024
Management Tracks
New CEOs at Evox and George Medicines
Plus: Stoke hires Thomas Leggett as CFO, and updates from TScan, Rinri, Tevogen and more
BioCentury | Jan 6, 2024
Finance
Jan. 5 Quick Takes: Metagenomi, ArriVent file for IPO
Plus: Immunic eyes $240M private placement and updates from Applied Therapeutics and Novartis
BioCentury | Dec 16, 2023
Management Tracks
Mistras, Martin join Viatris
Plus: Nassim Usman at the helm at Totus as it raises $66M series B round, and updates from Tourmaline, HKEX, CIRM, CorMedix and RiverVest
BioCentury | Dec 7, 2023
Management Tracks
Versanis vet Pruzanski becomes Abcuro’s chair
Plus: Alentis hires Velji as CBO and updates from Empress, Ribbon, Octave, Camena, OM and Transgene
BioCentury | Dec 5, 2023
Management Tracks
Glucksmann at the helm at Sensorium
Plus: CEO, CMO out at Theseus and updates from Zenas, Nanoscope, Immunitas and more
BioCentury | Nov 18, 2023
Finance
Nov. 17 Quick Takes: WuXi XDC’s big gain in first Hong Kong trading day
Plus: Obesity play Carmot seeking NASDAQ IPO and updates from AZ, Astellas, Merck and Lilly
Items per page:
1 - 10 of 881